Holen Sie sich die Stockscreener-App
27.70
1.78%
0.485
Handel nachbörslich:
27.67
-0.035
-0.13%
Schlusskurs vom Vortag:
$27.22
Offen:
$27.16
24-Stunden-Volumen:
612.54K
Relative Volume:
0.77
Marktkapitalisierung:
$1.20B
Einnahmen:
$78.02M
Nettoeinkommen (Verlust:
$-73.37M
KGV:
-20.99
EPS:
-1.32
Netto-Cashflow:
$-62.06M
1W Leistung:
+16.65%
1M Leistung:
+24.46%
6M Leistung:
+134.19%
1J Leistung:
+0.00%
1-Tages-Spanne:
$26.00
$28.41
1-Wochen-Bereich:
$23.45
$30.47
52-Wochen-Spanne:
$8.89
$30.47
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Vergleichen Sie BBNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
27.70 | 1.20B | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Beta Bionics Announces Participation at Upcoming Investor Conferences - The Manila Times
Beta Bionics (BBNX) Q3 2025 Earnings Transcript - AOL.com
Beta Bionics Inc. (BBNX.US): Solid 3Q’25 Results But Valuation Full at Current Levels - Smartkarma
Will Beta Bionics Inc. price bounce be sustainableJuly 2025 Catalysts & Detailed Earnings Play Strategies - newser.com
Beta Bionics Inc. stock chart pattern explained2025 Top Gainers & Scalable Portfolio Growth Methods - newser.com
Is now a turning point for Beta Bionics Inc.Gap Down & Verified Stock Trade Ideas - newser.com
What drives Beta Bionics Inc stock priceMean Reversion Trades & Rapid Portfolio Appreciation - earlytimes.in
Will Beta Bionics Inc. continue its uptrendJuly 2025 Pullbacks & Low Drawdown Investment Strategies - newser.com
Regression analysis insights on Beta Bionics Inc. performanceWeekly Profit Report & Verified Stock Trade Ideas - newser.com
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Beta Bionics, Inc. (NASDAQ:BBNX) Sees Significant Drop in Short Interest - MarketBeat
Beta Bionics (NASDAQ:BBNX) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Is Beta Bionics Inc. stock positioned for long term growth2025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
Leerink Partnrs Predicts Higher Earnings for Beta Bionics - MarketBeat
Beta Bionics raises 2025 revenue guidance to $96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion - MSN
Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say - MSN
Comparing Beta Bionics Inc. in custom built stock radarsJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - newser.com
Analyzing Beta Bionics Inc. with multi timeframe chartsNew Guidance & Capital Efficiency Focused Strategies - newser.com
Will a bounce in Beta Bionics Inc. offer an exitWeekly Market Outlook & Daily Price Action Insights - newser.com
Published on: 2025-10-31 02:01:27 - newser.com
Midday Stock Roundup: BJ’s Surges After Earnings top Estimates - Orange County Business Journal
Is Beta Bionics Inc. stock attractive for retirement portfoliosEarnings Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Beta Bionics Inc (BBNX) Q3 2025 Earnings Call Highlights: Record Growth and Strategic Challenges By GuruFocus - Investing.com Canada
Beta Bionics (BBNX) Valuation Concerns Mount as Forecast Revenue Growth Far Exceeds Market Average - Yahoo Finance
Beta Bionics' (BBNX) "Overweight" Rating Reaffirmed at Piper Sandler - MarketBeat
Beta Bionics (NASDAQ:BBNX) Reaches New 1-Year High After Earnings Beat - MarketBeat
Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10 - Yahoo Finance
Beta Bionics, Inc. (NASDAQ:BBNX) Stocks Shoot Up 35% But Its P/S Still Looks Reasonable - 富途牛牛
BBNX Crosses Above Average Analyst Target - Nasdaq
Beta Bionics, Inc. (NASDAQ:BBNX) Looks Just Right With A 35% Price Jump - simplywall.st
Beta Bionics Reports Strong Q3 Growth Amid Challenges - TipRanks
Stifel Reiterates Beta Bionics (BBNX) Buy Recommendation - Nasdaq
Beta Bionics (NASDAQ:BBNX) Releases Earnings Results - MarketBeat
Truist Raises Price Target on Beta Bionics to $32 From $28, Keeps Buy Rating - MarketScreener
Beta Bionics price target raised to $31 from $26 at Stifel - TipRanks
Beta Bionics, Inc. (BBNX) stock price, news, quote and history - Yahoo! Finance UK
Beta Bionics Reports Strong Q3 Growth and Raises Guidance - TipRanks
Transcript : Beta Bionics, Inc., Q3 2025 Earnings Call, Oct 28, 2025 - MarketScreener
Beta Bionics Q3 2025 Earnings Call Transcript - MarketBeat
(BBNX) Beta Bionics Expects Full Year 2025 Revenue $96.5 Million, vs. FactSet Est of $91.4 Million - MarketScreener
Earnings Flash (BBNX) Beta Bionics Posts Q3 Loss $-0.33, vs. FactSet Est of $-0.42 - MarketScreener
Beta Bionics (NASDAQ:BBNX) Stock Price Up 8.5%Time to Buy? - MarketBeat
BETA BIONICS Earnings Results: $BBNX Reports Quarterly Earnings - Quiver Quantitative
Beta Bionics, Inc. (BBNX) Q3 FY2025 earnings call transcript - Yahoo Finance
Beta Bionics, Inc. SEC 10-Q Report - TradingView
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):